Personalized and preventive mHealth predicting life-threatening arrhythmias in cardiac patients

Amsterdam University Medical Centers (AUMC)0 个研究点目标入组 400 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•- ICD or CRT-D implantation for either primary or secondary prevention less than 5 years prior to enrolment;
•- Participation in the remote monitoring program at AUMC or RIGS;
•- Patients =18 years old
•- Having received appropriate or inappropriate ICD therapy or proof of ventricular arrhythmias in the last 8 years prior to enrolment

•A potential subject who meets any of the following criteria will be excluded from participation for both the development-study and feasibility-study:
•- Unwilling to participate;
•- Study participants with a life expectancy of less than one year;
•- Study participants with circumstances that prevent follow-up (emigration, change of hospital for follow-up, dropping out of the remote monitoring program);
•- Study participants who are unable to wear the accelerometer wrist-band (e.g. allergic to the material);
•- Clinically unstable study participants;
•- End-stage of heart failure (NYHA-class IV);
•- Study participants unable to complete a questionnaire;
•- Does not understand the local language (Dutch or Danish);
•- Serious physical disability (e.g. wheelchair-bound);
•- A planned ablation for ventricular tachycardia (VT);
•- Significant movement disorder (i.e. hemiplegia or Parkinson’s disease or similar).

发起方

Amsterdam University Medical Centers (AUMC)